|Barry Sall, RAC|
Barry Sall is a principal consultant of PAREXEL Consulting (Waltham, MA). His expertise includes strategic regulatory consulting for medical device and combination products at all stages of development. Mr. Sall manages the preparation of FDA marketing applications for medical devices and provides regulatory assistance related to conducting clinical trials and assuring quality systems compliance. He also applies his expertise to regulatory due diligence efforts. He regularly participates in training activities for clients, including joint efforts with FDA. Prior to joining PAREXEL, Mr. Sall supervised the quality control and regulatory affairs departments at Integrated Genetics. Previously, he served as a production chemist for New England Nuclear Corp. Mr. Sall holds a BA in biology from Boston University. He has been regulatory affairs certified by RAPS. Mr. Sall has been a member of MD&DI’s Editorial Advisory Board since 1997 and has written several articles about medical device industry issues. He is also a frequent speaker at industry forums and is currently an adjunct assistant professor at the Massachusetts College of Pharmacy and Health Sciences, where he teaches in their graduate program on regulatory affairs and health policy.